Cited 5 time in webofscience Cited 7 time in scopus

Selective novel inverse agonists for human GPR43 augment GLP-1 secretion

Title
Selective novel inverse agonists for human GPR43 augment GLP-1 secretion
Authors
Park, BO[Park, Bi-Oh]Kim, SH[Kim, Seong Heon]Kong, GY[Kong, Gye Yeong]Kim, DH[Kim, Da Hui]Kwon, MS[Kwon, Mi So]Lee, SU[Lee, Su Ui]Kim, MO[Kim, Mun-Ock]Cho, S[Cho, Sungchan]Lee, S[Lee, Sangku]Lee, HJ[Lee, Hyun-Jun]Han, SB[Han, Sang-Bae]Kwak, YS[Kwak, Young Shin]Lee, SB[Lee, Sung Bae]Kim, S[Kim, Sunhong]
DGIST Authors
Lee, SB[Lee, Sung Bae]
Issue Date
2016-01-15
Citation
European Journal of Pharmacology, 771, 1-9
Type
Article
Article Type
Article
Keywords
Agents Interacting With Transmitter, Hormone or Drug ReceptorsBTI-A-202BTI-A-292BTI-A-404Calcium IonCompetitive InhibitionControlled StudyCyclic AMPCytoplasmDrug IdentificationDrug PotencyDrug ScreeningDrug SelectivityDrug StructureG Protein-Coupled ReceptorGLP-1Glucagon Like Peptide 1GPR43High Throughput ScreeningImmunoglobulin Enhancer Binding ProteinInverse AgonistMitogen-Activated Protein KinaseMitogen-Activated Protein Kinase P38Priority JournalProtein GPR43Protein SecretionSCFASignal TransductionStructure Activity RelationUnclassified Drug
ISSN
0014-2999
Abstract
GPR43/Free Fatty Acid Receptor 2 (FFAR2) is known to be activated by short-chain fatty acids and be coupled to Gi and Gq family of heterotrimeric G proteins. GPR43 is mainly expressed in neutrophils, adipocytes and enteroendocrine cells, implicated to be involved in inflammation, obesity and type 2 diabetes. However, several groups have reported the contradictory data about the physiological functions of GPR43, so that its roles in vivo remain unclear. Here, we demonstrate that a novel compound of pyrimidinecarboxamide class named as BTI-A-404 is a selective and potent competitive inverse agonist of human GPR43, but not the murine ortholog. Through structure-activity relationship (SAR), we also found active compound named as BTI-A-292. These regulators increased the cyclic AMP level and reduced acetate-induced cytoplasmic Ca2+ level. Furthermore, we show that they modulated the downstream signaling pathways of GPR43, such as ERK, p38 MAPK, and NF-κB. It was surprising that two compounds augmented the secretion of glucagon-like peptide 1 (GLP-1) in NCI-H716 cell line. Collectively, these novel and specific competitive inhibitors regulate all aspects of GPR43 signaling and the results underscore the therapeutic potential of them. © 2015 Elsevier B.V. All rights reserved.
URI
http://hdl.handle.net/20.500.11750/2735
DOI
10.1016/j.ejphar.2015.12.010
Publisher
Elsevier B.V.
Related Researcher
  • Author Lee, Sung Bae SB LAB(Lab of Neurodegenerative diseases and Aging)
  • Research Interests Cellular mechanism of neurodegenerative diseases; Neuronal maintenance and remodeling; 퇴행성 뇌질환의 세포기전; 신경계 유지 및 리모델링 연구
Files:
There are no files associated with this item.
Collection:
Brain and Cognitive SciencesETC1. Journal Articles


qrcode mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE